ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $772 | +243.1% | 605,700 | -12.2% | 0.00% | – |
| Q2 2023 | $225 | -8.2% | 689,713 | +21.1% | 0.00% | – |
| Q1 2023 | $245 | -44.9% | 569,700 | -32.2% | 0.00% | -100.0% |
| Q4 2022 | $445 | -99.9% | 840,500 | -24.3% | 0.00% | 0.0% |
| Q3 2022 | $813,000 | -3.2% | 1,110,035 | +50.7% | 0.00% | 0.0% |
| Q2 2022 | $840,000 | +24.8% | 736,600 | +124.3% | 0.00% | 0.0% |
| Q1 2022 | $673,000 | -39.9% | 328,400 | -15.4% | 0.00% | 0.0% |
| Q4 2021 | $1,119,000 | -26.1% | 388,385 | +8.8% | 0.00% | -50.0% |
| Q3 2021 | $1,514,000 | +218.7% | 356,982 | +147.9% | 0.00% | +100.0% |
| Q4 2020 | $475,000 | +666.1% | 144,000 | +674.2% | 0.00% | – |
| Q3 2020 | $62,000 | -88.7% | 18,600 | -89.9% | 0.00% | -100.0% |
| Q4 2018 | $547,000 | – | 184,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 4,898,927 | $6,246,132 | 0.70% |
| Yakira Capital Management, Inc. | 620,019 | $790,524 | 0.22% |
| Crystalline Management Inc. | 230,817 | $294,292 | 0.21% |
| DELTEC ASSET MANAGEMENT LLC | 475,000 | $605,625 | 0.14% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,283,979 | $2,912,073 | 0.12% |
| PenderFund Capital Management Ltd. | 123,444 | $213 | 0.06% |
| FIFTH LANE CAPITAL, LP | 100,000 | $127,000 | 0.04% |
| CSS LLC/IL | 476,831 | $607,960 | 0.04% |
| Penserra Capital Management LLC | 220,858 | $280 | 0.01% |
| King Wealth Management Group | 16,000 | $20 | 0.00% |